DSGN short interest
Design Therapeutics Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 6,616,513 |
|---|---|
| Change vs prior report | 1,155,005 (+21.1%) |
| Change over six months | +218.1% |
| Days to cover | 8.69 (sector: 3.78) |
| Average daily volume | 761,007 |
| Rank in Healthcare | #169 of 922 by days to cover |
DSGN short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 6,616,513 | +21.1% | 8.69 | 761,007 |
| 2026-09-15 | 5,461,508 | -1.5% | 7.26 | 751,944 |
| 2026-08-31 | 5,542,463 | -6.5% | 8.98 | 617,267 |
| 2026-08-14 | 5,925,557 | -0.5% | 15.23 | 389,063 |
| 2026-07-31 | 5,952,223 | +5.0% | 11.96 | 497,787 |
| 2026-07-15 | 5,669,571 | -0.8% | 6.36 | 891,591 |
| 2026-06-30 | 5,715,760 | +23.4% | 5.16 | 1,107,491 |
| 2026-06-15 | 4,631,963 | +19.5% | 6.25 | 741,594 |
| 2026-05-29 | 3,876,597 | +33.5% | 1.91 | 2,026,572 |
| 2026-05-15 | 2,903,656 | +25.1% | 5.34 | 543,946 |
| 2026-04-30 | 2,321,731 | +3.7% | 3.57 | 651,111 |
| 2026-04-15 | 2,238,096 | +7.6% | 6.81 | 328,564 |
| 2026-03-31 | 2,079,920 | +6.0% | 6.22 | 334,451 |
| 2026-03-13 | 1,961,343 | +12.8% | 9.20 | 213,131 |
| 2026-02-27 | 1,738,497 | -3.6% | 9.37 | 185,626 |
| 2026-02-13 | 1,803,282 | -9.5% | 9.42 | 191,506 |
| 2026-01-30 | 1,993,557 | -14.0% | 5.63 | 354,260 |
| 2026-01-15 | 2,317,010 | +3.8% | 8.87 | 261,130 |
| 2025-12-31 | 2,232,251 | +5.3% | 3.18 | 702,027 |
| 2025-12-15 | 2,119,760 | +0.7% | 7.27 | 291,587 |
| 2025-11-28 | 2,105,995 | +5.1% | 6.79 | 310,145 |
| 2025-11-14 | 2,004,465 | +8.4% | 3.21 | 623,998 |
| 2025-10-31 | 1,849,031 | -3.1% | 15.02 | 123,100 |
| 2025-10-15 | 1,908,895 | -46.2% | 7.39 | 258,192 |
| 2025-09-30 | 3,550,420 | -3.6% | 16.97 | 209,188 |
import finzdata as yf
yf.Ticker("DSGN").short_interest # every report since 2017
yf.Client().short_interest(["DSGN"], start="2018-01-01")Healthcare short interest · DSGN price history · Who owns DSGN · All short interest